Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Vigil Neuroscience Q4 EPS $(0.57) Misses $(0.53) Estimate, Cash Balance of $117.9M

Author: Benzinga Newsdesk | March 26, 2024 07:28am
Vigil Neuroscience (NASDAQ:VIGL) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.53) by 7.55 percent. This is a 18.75 percent decrease over losses of $(0.48) per share from the same period last year.

Posted In: VIGL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist